Influence of tiotropium bromide (TB) on the severity of clinical, functional symptoms and health-related quality of life (HRQL) in COPD patients (pts)

L. Konopkina, T. Pertseva, V. Berezovskyi, B. Basina (Dnipropetrovsk, Ukraine)

Source: Annual Congress 2011 - COPD management
Session: COPD management
Session type: Thematic Poster Session
Number: 550
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Konopkina, T. Pertseva, V. Berezovskyi, B. Basina (Dnipropetrovsk, Ukraine). Influence of tiotropium bromide (TB) on the severity of clinical, functional symptoms and health-related quality of life (HRQL) in COPD patients (pts). Eur Respir J 2011; 38: Suppl. 55, 550

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of smoking on quality of life (QoL) and dyspnoea in patients with COPD
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008


NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011


The level of health-related quality of life (HRQL) in patients with moderate to severe COPD and its relationship to symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 249s
Year: 2002

Determinants of health-related quality of life (HRQL) in patients with COPD
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008

Is pulmonary rehabilitation (PR) effective in improving the BODE index (BI) and quality of life (QoL) in the elderly COPD patients?
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005

Evaluation of quality of life (QOL) in asthma patients during 6 months formoterol therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 44s
Year: 2001

Quality of life (QOL) and pulmonary rehabilitation (PRP) : Functional correlates in asthma and COPD outpatients
Source: International Congress 2018 – Asthma and drugs
Year: 2018

Health-related quality of life (HRQL) and use of formoterol in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 55s
Year: 2001

Quality of life (QOL) and clinical phenotypes in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 809s
Year: 2006

Analysis of the level of dyspnea and health-related quality of life (HRQoL) in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 250s
Year: 2002

Pulmonary rehabilitation outcome: quality of life (QoL) and COPD severity
Source: Eur Respir J 2004; 24: Suppl. 48, 633s
Year: 2004

Health-related quality of life (HRQL) and patient-reported outcomes (PRO) in COPD patients receiving add-on-therapy with EPs® 7630
Source: Annual Congress 2011 - COPD management
Year: 2011

Relationship between dyspnea levels and health-related quality of life (HRQoL) in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 240s
Year: 2003

Dyspnea level and health- related quality of life (HRQoL) analysis in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 56s
Year: 2004

The relationship between dyspnea and detection of depression in COPD patients (pts)
Source: International Congress 2015 – Different data in COPD
Year: 2015


Indacaterol once-daily improves health-related quality of life (HRQOL) in COPD patients: a 52-week study
Source: Annual Congress 2009 - New bronchodilators
Year: 2009

Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year
Source: Eur Respir J 2010; 35: 1022-1030
Year: 2010



Effect of psychological factors on exercise capacity (EC) and health-related quality of life (HRQL) in COPD undergoing pulmonary rehabilitation (PR)
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015

Indacaterol/glycopyrronium (IND/GLY) is superior to salmeterol/fluticasone (SFC) in improving the health status of patients with moderate-to-very severe COPD: Results from the FLAME study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016

Quality of life (QoL) in asthma 1 year after pulmonary rehabilitation (PR)
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011